Literature DB >> 12859721

Peripheral neuropathy in liver cirrhosis.

Parampreet S Kharbanda1, Sudesh Prabhakar, Yogesh K Chawla, Chandi P Das, Puneet Syal.   

Abstract

BACKGROUND AND AIMS: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported. The causal relationship of liver disease to neuropathy has been questioned. This study was designed to evaluate the incidence and character of peripheral neuropathy in patients with liver cirrhosis. The effect of alcohol consumption, severity of liver disease and encephalopathy on the incidence and severity of neuropathy were also studied.
METHODS: Patients having an identifiable cause of peripheral neuropathy, except alcohol, were excluded from the study. Patients with evidence of vitamin B12 deficiency or diabetes were also excluded from the study. In this study, 33 patients with liver cirrhosis were evaluated clinically and electrophysiologically to detect any evidence of peripheral neuropathy. Nerve conduction studies were performed in the upper and lower limbs using surface electrodes. These patients also underwent a detailed clinical examination.
RESULTS: Clinical signs of peripheral neuropathy were found in seven (21%) patients. Nerve conduction studies were abnormal in 24 (73%) patients. The pattern of involvement was predominantly of an axonal sensory motor polyneuropathy. Neuropathy was found both in patients with alcohol-related and non-alcohol-related cirrhosis. The presence of encephalopathy did not have a significant bearing on the incidence and severity of neuropathy. The neuropathy was also not significantly related to the severity of liver disease.
CONCLUSIONS: The present study reveals that a significant number of patients with liver cirrhosis show evidence of peripheral neuropathy, which is present regardless of the etiology of cirrhosis, and is subclinical in a majority of these patients. The cause of neuropathy was probably the liver disease itself, as the incidence and severity of neuropathy in the alcohol-related cirrhosis, although higher, was not significantly different from the neuropathy in patients with non-alcohol-related cirrhosis.

Entities:  

Mesh:

Year:  2003        PMID: 12859721     DOI: 10.1046/j.1440-1746.2003.03023.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Neuropathies in hepatitis C-related liver cirrhosis.

Authors:  Nadia Abdelaaty Abdelkader; Doaa Zakaria Zaky; Hossam Afifi; Wessam Elsayed Saad; Said Ibrahim Shalaby; Mohamed Awad Mansour
Journal:  Indian J Gastroenterol       Date:  2014-10-12

2.  Thalidomide for treating metastatic hepatocellular carcinoma: a pilot study.

Authors:  Sang Hoon Han; Se Hoon Park; Jung Ho Kim; Jong Jun Lee; So Young Kwon; Oh Sang Kwon; Sun Suk Kim; Ju Hyun Kim; Keon Kug Kim; Yeon Ho Park; Jeong Nam Lee; Eunmi Nam; Soo-Mee Bang; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Lee
Journal:  Korean J Intern Med       Date:  2006-12       Impact factor: 2.884

3.  Magnitude of peripheral neuropathy in cirrhosis of liver patients from central rural India.

Authors:  Jyoti Jain; Ramji Singh; Shashank Banait; Nitin Verma; Satish Waghmare
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

Review 4.  Epidemiology of Peripheral Neuropathy: An Indian Perspective.

Authors:  Sweety Trivedi; Alak Pandit; Goutam Ganguly; Shyamal Kumar Das
Journal:  Ann Indian Acad Neurol       Date:  2017 Jul-Sep       Impact factor: 1.383

5.  Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5.

Authors:  Johanna Abrigo; Fabián Campos; Francisco Gonzalez; Francisco Aguirre; Andrea Gonzalez; Camila Huerta-Salgado; Sabrina Conejeros; Felipe Simon; Marco Arrese; Daniel Cabrera; Alvaro A Elorza; Claudio Cabello-Verrugio
Journal:  Int J Mol Sci       Date:  2020-10-25       Impact factor: 5.923

Review 6.  Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Andrea Gonzalez; Camila Huerta-Salgado; Josué Orozco-Aguilar; Francisco Aguirre; Franco Tacchi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Oxid Med Cell Longev       Date:  2020-10-19       Impact factor: 6.543

Review 7.  Pathophysiological Mechanisms That Alter the Autonomic Brain-Liver Communication in Metabolic Diseases.

Authors:  Anisia Silva; Alexandre Caron
Journal:  Endocrinology       Date:  2021-11-01       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.